Patients undergoing intragastric balloon achieve approximately 50% of their target weight loss in the first month postoperatively: an MBSAQIP analysis

Priscila R. Armijo, Bhavani Pokala, Laura Flores, Melissa A. Leon, Dmitry Oleynikov, Vishal Kothari

Research output: Contribution to journalArticle

Abstract

Background: Intragastric balloon (IGB) placement can provide a mean percent total weight loss (%TWL) of 10.2% at 6-month follow-up. Objectives: We aimed to evaluate 30-day outcomes and safety of patients undergoing IGB placement. Setting: Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Methods: The 2016 to 2017 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program was queried for adult patients who underwent primary IGB placement. Demographic characteristics and preoperative risk factors were collected. Postoperative outcomes included %TWL, percent excess weight loss, and complications rates and causes. Subset analysis was done for outcomes comparison between surgeons or gastroenterologists performing the procedure. Statistical analysis was performed using SPSS 25.0. Results: A total of 1221 patients were included. The majority was female (81.9%), Caucasian (81.2%), with a mean age of 48 ± 11.3 years and a mean preoperative body mass index of 34.9 ± 11.2 kg/m2. Of patients, 98.8% were discharged within 24 hours of the procedure. Two patients were admitted to the intensive care unit, and 7.2% received postoperative treatment for dehydration. Reoperation and readmission rates were 1.1% and 7.2%, respectively, mainly due to nausea, vomiting, and poor nutritional status (n = 22). The intervention rate was 6.2%. Patients in this cohort achieved a mean %TWL of 6.2% (standard deviation, 5.52%) and mean TWL of 6.8 kg within 30 days postoperatively (n = 147; 24–30 d). Conclusions: Our data show patients met approximately 50% of their target weight loss 30 days after IGB placement. Nausea, vomiting, and poor nutrition status were the most common complications within 30 days of the procedure. Long-term follow-up is necessary to determine if these patients are able to sustain their weight loss and for how long.

Original languageEnglish (US)
Pages (from-to)2060-2065
Number of pages6
JournalSurgery for Obesity and Related Diseases
Volume15
Issue number12
DOIs
StatePublished - Dec 2019

Fingerprint

Weight Loss
Bariatric Surgery
Accreditation
Quality Improvement
Nutritional Status
Nausea
Vomiting
Patient Safety
Reoperation
Dehydration
Intensive Care Units
Body Mass Index
Demography

Keywords

  • Intragastric balloon
  • Obesity
  • Total weight loss
  • Weight loss

ASJC Scopus subject areas

  • Surgery

Cite this

Patients undergoing intragastric balloon achieve approximately 50% of their target weight loss in the first month postoperatively : an MBSAQIP analysis. / Armijo, Priscila R.; Pokala, Bhavani; Flores, Laura; Leon, Melissa A.; Oleynikov, Dmitry; Kothari, Vishal.

In: Surgery for Obesity and Related Diseases, Vol. 15, No. 12, 12.2019, p. 2060-2065.

Research output: Contribution to journalArticle

Armijo, Priscila R. ; Pokala, Bhavani ; Flores, Laura ; Leon, Melissa A. ; Oleynikov, Dmitry ; Kothari, Vishal. / Patients undergoing intragastric balloon achieve approximately 50% of their target weight loss in the first month postoperatively : an MBSAQIP analysis. In: Surgery for Obesity and Related Diseases. 2019 ; Vol. 15, No. 12. pp. 2060-2065.
@article{313dc273450e45888ce4efea8c615287,
title = "Patients undergoing intragastric balloon achieve approximately 50{\%} of their target weight loss in the first month postoperatively: an MBSAQIP analysis",
abstract = "Background: Intragastric balloon (IGB) placement can provide a mean percent total weight loss ({\%}TWL) of 10.2{\%} at 6-month follow-up. Objectives: We aimed to evaluate 30-day outcomes and safety of patients undergoing IGB placement. Setting: Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Methods: The 2016 to 2017 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program was queried for adult patients who underwent primary IGB placement. Demographic characteristics and preoperative risk factors were collected. Postoperative outcomes included {\%}TWL, percent excess weight loss, and complications rates and causes. Subset analysis was done for outcomes comparison between surgeons or gastroenterologists performing the procedure. Statistical analysis was performed using SPSS 25.0. Results: A total of 1221 patients were included. The majority was female (81.9{\%}), Caucasian (81.2{\%}), with a mean age of 48 ± 11.3 years and a mean preoperative body mass index of 34.9 ± 11.2 kg/m2. Of patients, 98.8{\%} were discharged within 24 hours of the procedure. Two patients were admitted to the intensive care unit, and 7.2{\%} received postoperative treatment for dehydration. Reoperation and readmission rates were 1.1{\%} and 7.2{\%}, respectively, mainly due to nausea, vomiting, and poor nutritional status (n = 22). The intervention rate was 6.2{\%}. Patients in this cohort achieved a mean {\%}TWL of 6.2{\%} (standard deviation, 5.52{\%}) and mean TWL of 6.8 kg within 30 days postoperatively (n = 147; 24–30 d). Conclusions: Our data show patients met approximately 50{\%} of their target weight loss 30 days after IGB placement. Nausea, vomiting, and poor nutrition status were the most common complications within 30 days of the procedure. Long-term follow-up is necessary to determine if these patients are able to sustain their weight loss and for how long.",
keywords = "Intragastric balloon, Obesity, Total weight loss, Weight loss",
author = "Armijo, {Priscila R.} and Bhavani Pokala and Laura Flores and Leon, {Melissa A.} and Dmitry Oleynikov and Vishal Kothari",
year = "2019",
month = "12",
doi = "10.1016/j.soard.2019.05.024",
language = "English (US)",
volume = "15",
pages = "2060--2065",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Patients undergoing intragastric balloon achieve approximately 50% of their target weight loss in the first month postoperatively

T2 - an MBSAQIP analysis

AU - Armijo, Priscila R.

AU - Pokala, Bhavani

AU - Flores, Laura

AU - Leon, Melissa A.

AU - Oleynikov, Dmitry

AU - Kothari, Vishal

PY - 2019/12

Y1 - 2019/12

N2 - Background: Intragastric balloon (IGB) placement can provide a mean percent total weight loss (%TWL) of 10.2% at 6-month follow-up. Objectives: We aimed to evaluate 30-day outcomes and safety of patients undergoing IGB placement. Setting: Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Methods: The 2016 to 2017 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program was queried for adult patients who underwent primary IGB placement. Demographic characteristics and preoperative risk factors were collected. Postoperative outcomes included %TWL, percent excess weight loss, and complications rates and causes. Subset analysis was done for outcomes comparison between surgeons or gastroenterologists performing the procedure. Statistical analysis was performed using SPSS 25.0. Results: A total of 1221 patients were included. The majority was female (81.9%), Caucasian (81.2%), with a mean age of 48 ± 11.3 years and a mean preoperative body mass index of 34.9 ± 11.2 kg/m2. Of patients, 98.8% were discharged within 24 hours of the procedure. Two patients were admitted to the intensive care unit, and 7.2% received postoperative treatment for dehydration. Reoperation and readmission rates were 1.1% and 7.2%, respectively, mainly due to nausea, vomiting, and poor nutritional status (n = 22). The intervention rate was 6.2%. Patients in this cohort achieved a mean %TWL of 6.2% (standard deviation, 5.52%) and mean TWL of 6.8 kg within 30 days postoperatively (n = 147; 24–30 d). Conclusions: Our data show patients met approximately 50% of their target weight loss 30 days after IGB placement. Nausea, vomiting, and poor nutrition status were the most common complications within 30 days of the procedure. Long-term follow-up is necessary to determine if these patients are able to sustain their weight loss and for how long.

AB - Background: Intragastric balloon (IGB) placement can provide a mean percent total weight loss (%TWL) of 10.2% at 6-month follow-up. Objectives: We aimed to evaluate 30-day outcomes and safety of patients undergoing IGB placement. Setting: Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Methods: The 2016 to 2017 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program was queried for adult patients who underwent primary IGB placement. Demographic characteristics and preoperative risk factors were collected. Postoperative outcomes included %TWL, percent excess weight loss, and complications rates and causes. Subset analysis was done for outcomes comparison between surgeons or gastroenterologists performing the procedure. Statistical analysis was performed using SPSS 25.0. Results: A total of 1221 patients were included. The majority was female (81.9%), Caucasian (81.2%), with a mean age of 48 ± 11.3 years and a mean preoperative body mass index of 34.9 ± 11.2 kg/m2. Of patients, 98.8% were discharged within 24 hours of the procedure. Two patients were admitted to the intensive care unit, and 7.2% received postoperative treatment for dehydration. Reoperation and readmission rates were 1.1% and 7.2%, respectively, mainly due to nausea, vomiting, and poor nutritional status (n = 22). The intervention rate was 6.2%. Patients in this cohort achieved a mean %TWL of 6.2% (standard deviation, 5.52%) and mean TWL of 6.8 kg within 30 days postoperatively (n = 147; 24–30 d). Conclusions: Our data show patients met approximately 50% of their target weight loss 30 days after IGB placement. Nausea, vomiting, and poor nutrition status were the most common complications within 30 days of the procedure. Long-term follow-up is necessary to determine if these patients are able to sustain their weight loss and for how long.

KW - Intragastric balloon

KW - Obesity

KW - Total weight loss

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=85074506332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074506332&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2019.05.024

DO - 10.1016/j.soard.2019.05.024

M3 - Article

C2 - 31668944

AN - SCOPUS:85074506332

VL - 15

SP - 2060

EP - 2065

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 12

ER -